Capstone Investment Advisors LLC Makes New Investment in Grail, Inc. (NASDAQ:GRAL)

Capstone Investment Advisors LLC purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 369,800 shares of the company's stock, valued at approximately $6,601,000. Capstone Investment Advisors LLC owned about 1.10% of Grail at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Crcm LP purchased a new stake in shares of Grail during the fourth quarter worth about $65,061,000. Primecap Management Co. CA purchased a new stake in Grail during the 4th quarter worth approximately $37,118,000. Baker BROS. Advisors LP acquired a new position in shares of Grail in the 4th quarter valued at approximately $29,098,000. Vanguard Group Inc. purchased a new position in shares of Grail during the 4th quarter valued at approximately $25,902,000. Finally, AQR Capital Management LLC acquired a new stake in shares of Grail during the fourth quarter worth approximately $14,828,000.

Grail Stock Performance

GRAL traded up $1.69 during trading on Thursday, reaching $36.40. The stock had a trading volume of 1,121,212 shares, compared to its average volume of 1,225,174. The stock has a 50 day moving average of $29.67 and a two-hundred day moving average of $25.41. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. Research analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Insider Activity

In other Grail news, CEO Robert P. Ragusa sold 94,035 shares of the company's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the completion of the sale, the chief executive officer now owns 734,627 shares of the company's stock, valued at $24,925,894.11. This represents a 11.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of the firm's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares in the company, valued at $17,461,797.60. The trade was a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 194,948 shares of company stock worth $6,583,130 in the last 90 days.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on GRAL. Canaccord Genuity Group assumed coverage on Grail in a report on Monday, April 21st. They issued a "buy" rating and a $32.00 price objective for the company. Morgan Stanley upped their price target on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.